Amenity Pharmaceuticals (Opc) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Company Age 10 Year, 7 Months
About Amenity Pharmaceuticals (Opc)
Company Details
- Location
Gorakhpur, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U93030UP2014OPC064887
- Company No.
064887
- Incorporation Date
14 Jul 2014
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Amenity Pharmaceuticals (Opc)?
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shailendra Pathak ![]() | Director | 14-Jul-2014 | Current |
Financial Performance of Amenity Pharmaceuticals (Opc).
Enhance accessibility to Amenity Pharmaceuticals (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Amenity Pharmaceuticals (Opc)?
Unlock access to Amenity Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Amenity Pharmaceuticals (Opc)?
Unlock and access historical data on people associated with Amenity Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Amenity Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amenity Pharmaceuticals (Opc)'s trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.